stella
beta
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer — Stella
Home
/
Nasopharyngeal Carcinoma
/
View on ClinicalTrials.gov
Recruiting
Back to Nasopharyngeal Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Italy
Asst Degli Spedali Civili Di Brescia, Brescia